Article
Cantor Fitzgerald Maintains Neutral on Merck & Co, Raises Price Target to $120
Cantor Fitzgerald analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Neutral and raises the price target from $116 to $120.
Comments
- No comments yet. Be the first to comment!